Format

Send to

Choose Destination
Antioxidants (Basel). 2018 Aug 30;7(9). pii: E115. doi: 10.3390/antiox7090115.

The Use of Intravenous Vitamin C as a Supportive Therapy for a Patient with Glioblastoma Multiforme.

Author information

1
Integrated Health Options Ltd., Auckland 1050, New Zealand. nicky@integratedhealthoptions.co.nz.
2
Department of Pathology & Biomedical Science, University of Otago, Christchurch 8140, New Zealand. anitra.carr@otago.ac.nz.
3
Feedback Research Ltd., Auckland 1050, New Zealand. selene@feedbackresearch.co.nz.

Abstract

Glioblastoma multiforme is a high grade malignant brain tumour with a poor prognosis. Here we report the case of a woman with glioblastoma who lived for over four years from diagnosis (median survival 12 months and 2% survival for three years), experiencing good quality of life for most of that time. She underwent initial debulking craniotomy, radiotherapy and chemotherapy, as well as having intravenous vitamin C infusions 2⁻3 times weekly over the four years from diagnosis. Her progress was monitored by blood tests, regular computerised tomography (CT) and magnetic resonance imaging (MRI) scans, clinical reviews and European Organization for the Research and Treatment of Cancer quality of life questionnaires (EORTC QLQ C30). Our case report highlights the benefits of intravenous vitamin C as a supportive therapy for patients with glioblastoma.

KEYWORDS:

ascorbic acid; glioblastoma; intravenous vitamin C; neoplasms; quality of life; vitamin C

Supplemental Content

Full text links

Icon for Multidisciplinary Digital Publishing Institute (MDPI) Icon for PubMed Central
Loading ...
Support Center